Editorial: Glycoconjugates in vaccines and immunotherapeutics
Front Immunol
.
2022 Aug 4:13:941474.
doi: 10.3389/fimmu.2022.941474.
eCollection 2022.
Authors
Sachin Shivatare
1
,
Kumar Sanjiv
2
,
Raghavendra Kikkeri
3
,
Roberto Adamo
4
Affiliations
1
Department of Chemistry, The Scripps Research Institute, La Jolla, CA, United States.
2
Karolinska Institutet, Science for Life Laboratory, Solna, Sweden.
3
Department of Chemistry, Indian Institute of Science Education and Research, Pune, India.
4
Research Centre, GlaxoSmithKline (GSK), Siena, Italy.
PMID:
35990665
PMCID:
PMC9386521
DOI:
10.3389/fimmu.2022.941474
No abstract available
Keywords:
adjuvants; cancer; glycoconjugates; infectious diseases; vaccines.
Publication types
Editorial
MeSH terms
Glycoconjugates
Immunotherapy
Vaccines*
Substances
Glycoconjugates
Vaccines